Search by Drug Name or NDC

    NDC 13107-0083-10 LORAZEPAM 0.5 mg/1 Details

    LORAZEPAM 0.5 mg/1

    LORAZEPAM is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Aurolife Pharma LLC. The primary component is LORAZEPAM.

    Product Information

    NDC 13107-0083
    Product ID 13107-083_82f8b652-862a-4f3b-9d95-146b732dfccf
    Associated GPIs 57100060000305
    GCN Sequence Number 003757
    GCN Sequence Number Description lorazepam TABLET 0.5 MG ORAL
    HIC3 H20
    HIC3 Description ANTI-ANXIETY - BENZODIAZEPINES
    GCN 14160
    HICL Sequence Number 004846
    HICL Sequence Number Description LORAZEPAM
    Brand/Generic Generic
    Proprietary Name LORAZEPAM
    Proprietary Name Suffix n/a
    Non-Proprietary Name LORAZEPAM
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 0.5
    Active Ingredient Units mg/1
    Substance Name LORAZEPAM
    Labeler Name Aurolife Pharma LLC
    Pharmaceutical Class Benzodiazepine [EPC], Benzodiazepines [CS]
    DEA Schedule CIV
    Marketing Category ANDA
    Application Number ANDA203572
    Listing Certified Through 2024-12-31

    Package

    NDC 13107-0083-10 (13107008310)

    NDC Package Code 13107-083-10
    Billing NDC 13107008310
    Package 10 TABLET in 1 BOTTLE (13107-083-10)
    Marketing Start Date 2017-03-24
    NDC Exclude Flag N
    Pricing Information N/A